Technical Analysis for FARN - Faron Pharmaceuticals Oy

Grade Last Price % Change Price Change
D 355.0 2.90% 10.00
FARN closed up 2.9 percent on Friday, April 16, 2021, on 63 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Up
Historical FARN trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Death Cross Bearish 2.90%
20 DMA Support Bullish 2.90%
NR7 Range Contraction 2.90%
Inside Day Range Contraction 2.90%
200 DMA Resistance Bearish 4.41%
50 DMA Resistance Bearish 4.41%
20 DMA Support Bullish 4.41%
Older End-of-Day Signals for FARN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Faron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Target Research Pharmaceutical Biotechnology Medicine Clinic Pipe Pharmaceuticals Cancer Branches Of Biology Targeting Medical Specialties Drugs Therapy Biopharmaceutical Respirator Tumor Immunotherapy Medical Research

Is FARN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 530.0
52 Week Low 216.0534
Average Volume 19,336
200-Day Moving Average 355.43
50-Day Moving Average 351.47
20-Day Moving Average 342.47
10-Day Moving Average 345.35
Average True Range 22.65
ADX 14.39
+DI 16.68
-DI 11.68
Chandelier Exit (Long, 3 ATRs ) 312.05
Chandelier Exit (Short, 3 ATRs ) 367.95
Upper Bollinger Band 363.82
Lower Bollinger Band 321.13
Percent B (%b) 0.79
BandWidth 12.46
MACD Line 1.77
MACD Signal Line 0.16
MACD Histogram 1.6059
Fundamentals Value
Market Cap 166.48 Million
Num Shares 46.9 Million
EPS -109.50
Price-to-Earnings (P/E) Ratio -3.24
Price-to-Sales 0.00
Price-to-Book 20.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 385.00
Resistance 3 (R3) 383.33 371.67 380.00
Resistance 2 (R2) 371.67 364.03 372.50 378.33
Resistance 1 (R1) 363.33 359.31 367.50 365.00 376.67
Pivot Point 351.67 351.67 353.75 352.50 351.67
Support 1 (S1) 343.33 344.03 347.50 345.00 333.33
Support 2 (S2) 331.67 339.31 332.50 331.67
Support 3 (S3) 323.33 331.67 330.00
Support 4 (S4) 325.00